SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 16.27 |
| Enterprise Value ($M) | 21.69 |
| Book Value ($M) | 79.14 |
| Book Value / Share | 13.38 |
| Price / Book | 0.21 |
| NCAV ($M) | -18.44 |
| NCAV / Share | -3.12 |
| Price / NCAV | -0.88 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.05 |
| Return on Assets (ROA) | -0.05 |
| Return on Equity (ROE) | -0.09 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.64 |
| Current Ratio | 2.70 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 58.55 |
| Assets | 156.13 |
| Liabilities | 76.99 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Renaissance Technologies Llc | 4.99 | -8.52 | |
| 13G/A | Caldwell Securities, Inc | 7.80 | 6.78 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,459 | 22,084 | 15.66 | |
| 142 | 8,118 | 1.75 | |
| 1,324 | 5,315 | 24.91 | |
| 5,374 | 38,373 | 14.00 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MNOV – MediciNova, Inc. | MRUS – Merus N.V. |
| MURA – Mural Oncology plc | NAMS – NewAmsterdam Pharma Company N.V. |
| NEUP – Neuphoria Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io